FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Axalta beats Q3 estimates, raises guidance, and secures a strategic BMW deal, signaling confidence in revenue growth despite near-term market caution.
Trump defends aggressive ICE raids, threatens to use military to bolster enforcement, despite criticism from local officials and civil-rights advocates.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Axalta beats Q3 estimates, raises guidance, and secures a strategic BMW deal, signaling confidence in revenue growth despite near-term market caution.
Trump defends aggressive ICE raids, threatens to use military to bolster enforcement, despite criticism from local officials and civil-rights advocates.